Sui Generis Oy is a limited company based in Espoo, registered in 2018. In the financial year ending 31.12.2025, revenue was 7 747 € and operating profit -44 t€; equity ratio 99.7 %. Its taxable income in 2024 was 118 t€ and its income taxes 24 t€.
Espoo: 112 new companies in 30 days
- Ilovite OyOhjelmistojen suunnittelu ja valmistus
- Kahvila Tuisku OyKahvilat ja muu alkoholittomien juomien tarjoilu
- Mizero OyErikoistumaton agentuuritoiminta
Financials
| Key figures | 31.12.2025 | 31.12.2024 | 31.12.2023 | 31.12.2022 |
|---|---|---|---|---|
| Revenue | 7 747 € | 5 605 € | 4 004 € | 0 € |
| Revenue change | 38,2 % | 40,0 % | – | – |
| EBITDA | -50 t€ | -11 t€ | -389 € | -1 099 € |
| EBITDA % | -646,6 % | -192,5 % | -9,7 % | – |
| Operating profit | -44 t€ | -3 290 € | -10 t€ | -1 099 € |
| Operating margin | -574,0 % | -58,7 % | -259,5 % | – |
| Net profit | 817 t€ | 651 t€ | 517 t€ | 501 t€ |
| Personnel costs | -236 € | -1 205 € | – | – |
| Equity ratio | 99,7 % | 98,8 % | 100,0 % | 100,0 % |
| Quick ratio | 382,96 | 75,33 | 1984,68 | – |
| Current ratio | 382,96 | 75,33 | 1984,68 | – |
| Debt to revenue | 86,6 % | 421,1 % | 15,8 % | – |
| Return on equity | 31,7 % | 33,6 % | 35,9 % | 49,9 % |
| Balance sheet total | 2,6 M€ | 2,0 M€ | 1,4 M€ | 1,0 M€ |
| Equity | 2,6 M€ | 1,9 M€ | 1,4 M€ | 1,0 M€ |
| Cash and bank | 281 t€ | 217 t€ | 292 t€ | 188 t€ |
Balance sheet
Income statement and balance sheet
Income statement
| 31.12.2025 | 31.12.2024 | 31.12.2023 | 31.12.2022 | |
|---|---|---|---|---|
| Turnover | 7 747 € | 5 605 € | 4 004 € | 0 € |
| Other operating income | 2 415 € | 8 280 € | 1 380 € | 0 € |
| Personnel expenses | 236 € | 1 205 € | – | – |
| Depreciations and reductions in value | 5 625 € | 7 500 € | -10 t€ | 0 € |
| Other operating expenses | 49 t€ | 8 470 € | -5 773 € | -1 099 € |
| Operating profit (loss) | -44 t€ | -3 290 € | -10 t€ | -1 099 € |
| Financial income and expenses + (-) | -868 t€ | -678 t€ | 528 t€ | 502 t€ |
| Profit (loss) before appropriations and taxes | 824 t€ | 674 t€ | 518 t€ | 501 t€ |
| Income taxes | 6 748 € | 24 t€ | -632 € | 0 € |
| Profit (loss) for the financial year | 817 t€ | 651 t€ | 517 t€ | 501 t€ |
Balance sheet
| 31.12.2025 | 31.12.2024 | 31.12.2023 | 31.12.2022 | |
|---|---|---|---|---|
| Non-current assets | 17 t€ | 184 t€ | 185 t€ | 12 t€ |
| Receivables | 206 t€ | 197 t€ | 272 t€ | 337 t€ |
| Cash in hand and at banks | 281 t€ | 217 t€ | 292 t€ | 188 t€ |
| Current assets | 2,6 M€ | 1,8 M€ | 1,3 M€ | 993 t€ |
| Assets | 2,6 M€ | 2,0 M€ | 1,4 M€ | 1,0 M€ |
| Share capital or other similar capital | 2 500 € | 2 500 € | 2 500 € | 2 500 € |
| Capital and reserves | 2,6 M€ | 1,9 M€ | 1,4 M€ | 1,0 M€ |
| Short-term liabilities | 6 706 € | 24 t€ | 632 € | 0 € |
| Liabilities | 6 706 € | 24 t€ | 632 € | 0 € |
All financial statement items (40)
| 31.12.2025 | 31.12.2024 | 31.12.2023 | 31.12.2022 | |
|---|---|---|---|---|
| Turnover | 7 747 € | 5 605 € | 4 004 € | 0 € |
| Other operating income | 2 415 € | 8 280 € | 1 380 € | 0 € |
| Personnel expenses | 236 € | 1 205 € | – | – |
| Depreciations and reductions in value | 5 625 € | 7 500 € | -10 t€ | 0 € |
| Other operating expenses | 49 t€ | 8 470 € | -5 773 € | -1 099 € |
| Operating profit (loss) | -44 t€ | -3 290 € | -10 t€ | -1 099 € |
| Financial income and expenses + (-) | -868 t€ | -678 t€ | 528 t€ | 502 t€ |
| Profit (loss) before appropriations and taxes | 824 t€ | 674 t€ | 518 t€ | 501 t€ |
| Income taxes | 6 748 € | 24 t€ | -632 € | 0 € |
| Profit (loss) for the financial year | 817 t€ | 651 t€ | 517 t€ | 501 t€ |
| Non-current assets | 17 t€ | 184 t€ | 185 t€ | 12 t€ |
| Receivables | 206 t€ | 197 t€ | 272 t€ | 337 t€ |
| Cash in hand and at banks | 281 t€ | 217 t€ | 292 t€ | 188 t€ |
| Current assets | 2,6 M€ | 1,8 M€ | 1,3 M€ | 993 t€ |
| Assets | 2,6 M€ | 2,0 M€ | 1,4 M€ | 1,0 M€ |
| Share capital or other similar capital | 2 500 € | 2 500 € | 2 500 € | 2 500 € |
| Capital and reserves | 2,6 M€ | 1,9 M€ | 1,4 M€ | 1,0 M€ |
| Short-term liabilities | 6 706 € | 24 t€ | 632 € | 0 € |
| Liabilities | 6 706 € | 24 t€ | 632 € | 0 € |
| Reductions in value of shares and holdings in current assets | 0 € | -11 t€ | 23 t€ | -29 t€ |
| Other shares, financial securities | 2,1 M€ | 1,4 M€ | 692 t€ | 468 t€ |
| Profit (loss) for the period, equity | 817 t€ | 651 t€ | 517 t€ | 501 t€ |
| Shares and holdings | 2,1 M€ | 1,4 M€ | 692 t€ | 468 t€ |
| Machinery and equipment | 17 t€ | 22 t€ | 30 t€ | 0 € |
| Other shares and similar rights of ownership | 545 € | 162 t€ | 155 t€ | 12 t€ |
| Pension expenses | 0 € | 1 136 € | – | – |
| Short-term prepayments and accrued income | 24 t€ | 0 € | – | – |
| Liabilities | 2,6 M€ | 2,0 M€ | 1,4 M€ | 1,0 M€ |
| Short-term accounts payable | 965 € | 0 € | – | – |
| Other interest and financial income from non-group companies | 14 t€ | 14 t€ | 15 t€ | 2 037 € |
| Short-term accrued expenses and deferred income | 5 741 € | 24 t€ | 632 € | 0 € |
| Interest expenses and other financial expenses for non-Group companies | 514 € | 45 € | – | – |
| Short-term receivables | 206 t€ | 197 t€ | 272 t€ | 337 t€ |
| Retained earnings | 1,8 M€ | 1,3 M€ | 920 t€ | 501 t€ |
| Other short-term receivables | 181 t€ | 197 t€ | 272 t€ | 337 t€ |
| Income from other investments under non-current assets, from other companies | 855 t€ | 653 t€ | 490 t€ | 529 t€ |
| Investments | 545 € | 162 t€ | 155 t€ | 12 t€ |
| Depreciations according to plan | 5 625 € | 7 500 € | -10 t€ | 0 € |
| Tangible assets | 17 t€ | 22 t€ | 30 t€ | 0 € |
| Other social security expenses | 236 € | 69 € | – | – |
From financial statements filed digitally (XBRL) with the Finnish Patent and Registration Office; ratios calculated from them. Equity ratio = (equity + accumulated appropriations) / (balance sheet total − advances received).
Taxes
Measured by taxable income, Sui Generis Oy is in the top quarter of the industry class security and commodity contracts brokerage (766 companies with taxable income; median 31 t€, 3,8 times the median).
Taxable income is the profit as calculated for taxation, not revenue. Public data from the Finnish Tax Administration; figures for 2025 are published in November 2026.